Long-acting therapies reshape hemophilia care beyond bleeding prevention < Hospital < Article
Treatment for hemophilia A is no longer limited to responding to bleeding episodes as they occur. To...
Article
Some patients are ‘dying while waiting’ as Korea’s liver transplant system falls into crisis < Policy < Article
The operating rooms are still there. So are the patients. But in hospitals across Korea, the teams that...
‘Early treatment of hepatitis B is key to preventing liver cancer and reducing healthcare costs’ < Hospital < Article
Hepatitis B is caused by the hepatitis B virus (HBV), a leading cause of chronic liver disease and...
Imfinzi-Imjudo dual immunotherapy offers new option for 1st-line treatment of liver cancer < Pharma < Article
As AstraZeneca launches Imjudo (tremelimumab) without health insurance coverage in May, Korean liver cancer patients will likely have...
